HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Kolh Selected Research
P Kolh Research Topics
Disease
4
Shock
12/2008 - 07/2003
2
Thrombosis (Thrombus)
07/2008 - 07/2003
2
Infections
07/2008 - 05/2003
2
Septic Shock (Toxic Shock Syndrome)
12/2003 - 07/2003
2
Myocardial Infarction
07/2003 - 07/2001
1
Emergence Delirium
12/2011
1
Aneurysm (Aneurysms)
07/2008
1
Rupture
07/2008
1
Coronary Thrombosis
07/2003
1
Infarction (Infarctions)
07/2003
1
Fistula
05/2003
1
Spasm (Spasms)
07/2001
1
Stroke (Strokes)
07/2001
1
Neoplasms (Cancer)
09/2000
Drug/Important Bio-Agent (IBA)
2
N- terbutyl- N'- (2- (4'- methylphenylamino)- 5- nitrobenzenesulfonyl)urea
IBA
07/2003 - 07/2003
1
Lipopolysaccharides
IBA
10/2006
1
Cytokines
IBA
10/2006
1
Thromboxanes
IBA
07/2003
1
Thromboxane Receptors (Thromboxane Receptor)
IBA
07/2003
1
Chlorides
IBA
07/2003
1
Evans Blue (Blue, Evans)
FDA Link
07/2003
1
ferric chloride
IBA
07/2003
1
Prostaglandin H2 Thromboxane A2 Receptors
IBA
07/2003
1
Adenosine Triphosphate (ATP)
IBA
07/2003
1
Thromboxane A2 (A2, Thromboxane)
IBA
07/2003
1
Urea (Carbamide)
FDA Link
Generic
07/2003
1
allogenic effect factor (AEF)
IBA
05/2003
1
Papaverine
IBA
07/2001
1
Nicardipine (Dagan)
FDA Link
Generic
07/2001
1
Parasympatholytics (Antispasmodics)
IBA
07/2001
1
Solutions
IBA
07/2001
Therapy/Procedure
3
Hemofiltration
12/2008 - 12/2003
2
Prostheses and Implants (Prosthesis)
07/2008 - 05/2003
1
Vascular Surgical Procedures
12/2011
1
Hemodiafiltration
12/2003
1
Blood Vessel Prosthesis
05/2003
1
Length of Stay
07/2001
1
Chemoradiotherapy
09/2000